Skip to main content
Heart logoLink to Heart
. 2000 Sep;84(Suppl 1):i26–i28. doi: 10.1136/heart.84.suppl_1.i26

Diabetic nephropathy: evidence for renoprotection and practice

C Mogensen
PMCID: PMC1766531  PMID: 10956317

Full Text

The Full Text of this article is available as a PDF (85.4 KB).

Figure 1  .

Figure 1  

The natural course of diabetic nephropathy in type 1 diabetes.

Figure 2  .

Figure 2  

Changes in albumin excretion rate by initial microalbuminuria status (from the EUCLID study).

Figure 3  .

Figure 3  

Impact of glycaemic and blood pressure control on diabetes related end points (from UKPDS).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agardh C. D., Garcia-Puig J., Charbonnel B., Angelkort B., Barnett A. H. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. J Hum Hypertens. 1996 Mar;10(3):185–192. [PubMed] [Google Scholar]
  2. Maschio G., Alberti D., Janin G., Locatelli F., Mann J. F., Motolese M., Ponticelli C., Ritz E., Zucchelli P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med. 1996 Apr 11;334(15):939–945. doi: 10.1056/NEJM199604113341502. [DOI] [PubMed] [Google Scholar]
  3. Mathiesen E. R., Hommel E., Hansen H. P., Smidt U. M., Parving H. H. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ. 1999 Jul 3;319(7201):24–25. doi: 10.1136/bmj.319.7201.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Mogensen C. E. Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction. BMJ. 1998 Sep 12;317(7160):693–694. doi: 10.1136/bmj.317.7160.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mogensen C. E. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes. 1990 Jul;39(7):761–767. doi: 10.2337/diab.39.7.761. [DOI] [PubMed] [Google Scholar]
  6. Pedersen M. M., Hansen K. W., Schmitz A., Sørensen K., Christensen C. K., Mogensen C. E. Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy. Kidney Int. 1992 Apr;41(4):883–890. doi: 10.1038/ki.1992.135. [DOI] [PubMed] [Google Scholar]
  7. Pedersen M. M., Schmitz A., Pedersen E. B., Danielsen H., Christiansen J. S. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabet Med. 1988 Sep;5(6):562–569. doi: 10.1111/j.1464-5491.1988.tb01052.x. [DOI] [PubMed] [Google Scholar]
  8. Rudberg S., Osterby R., Bangstad H. J., Dahlquist G., Persson B. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia. 1999 May;42(5):589–595. doi: 10.1007/s001250051199. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES